Treatment of Relapsed or Refractory Epstein-Barr Virus Positive T-cell Lymphoma With hNeo-T
Condition(s):T-cell LymphomaLast Updated:March 12, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):T-cell LymphomaLast Updated:March 12, 2024Recruiting
Condition(s):Solid TumorLast Updated:June 8, 2023Recruiting
Condition(s):Solid TumorLast Updated:April 4, 2023Recruiting
Condition(s):Solid TumorLast Updated:July 10, 2023Recruiting
Condition(s):Tumor Gastric; Tumor, ColorectalLast Updated:August 14, 2017Unknown status
Condition(s):Solid CancerLast Updated:February 2, 2023Completed
Condition(s):Hepatocellular CarcinomaLast Updated:November 22, 2023Recruiting
Condition(s):Bacterial VaginosisLast Updated:May 6, 2023Recruiting
Condition(s):Bacterial VaginosisLast Updated:July 9, 2021Completed
Condition(s):Colorectal NeoplasmsLast Updated:April 5, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.